From 2014.igem.org

Revision as of 20:14, 17 October 2014

Discussion & Future Work

It can be said that evolution is the most fascinating phenomena in biology. Evolution has the simplest strategy (mutation, selection, evolution), which, nevertheless, is so beautifully complex and wonderful. Ever since the birth of modern biology, humans continually try to mimic the evolution, hope to get a wide variety of products, including proteins, nucleic acids, and peptides and so on. However, the traditional method of artificial Evolution is time-consuming and has limited ability. This year, iGEM-SYSU China Team designed the IgEM, expecting that the various tedious work in artificial evolution can be integrated as one and to realize automatic directed evolution.

The current system

In early experiments, we have accomplished the key step in integration: the testing and verification of the Bacterial two-hybrid system. Using ligands and receptors with different interaction strength, we succeeded in producing the different intensities of reporter gene expression, which indicating that there is a correlation between the ligand-receptor interaction and reporter gene expression. Meanwhile, we also tried to integrate RNAT with Bacterial two-hybrid system, and have built the plasmid we want. In the future, we hope to use the similar way of IgEM to achieve a wider variety of directed evolution. For example, by imitating a variety of logic gates (Shown as figure1), we can construct different interaction way of the Bacterial two-hybrid system, so that we can implement different types of interaction evolution and not just the protein-protein binding.

<img src=""></a>

Meanwhile, we successfully knocked out gene3 which is closely related to phage packaging, and the rescue experiments is in progress. Now, we are trying to integrate B2H with M13 gene3 to test whether the gene3 producing by B2H system can rescue the defective phage. Next, we plan to knockout other phage genes, including the gene8, which has a similar function with gene3 and the gene2, which is associated with phage genomes replicate, and then, we will choose the best way to apply.

In addition, for the continual evolution, on the one hand we introduced the mutation mechanism by damaging the proofreading activity of the DNA polymerase, on the other hand we enhanced the error-prone repair ability of the E.coli, so that we can extend the follow-up directed evolution library. However, there is a huge problem: the mutation in our system is random, which can result in the collapse of the entire system. To avoid this problem, now we replace the infected E.coli with fresh E.coli to prevent mutations incorrectly appear in bacterial genomes. We consider, whether we can achieve the site-directed mutagenesis in the future.

Finally, in order to achieve the controllability of our device, we introduced the RNAT. Preliminary experiments have shown the RNAT function correctly . At present, the integration of RNAT and B2H has been completed, and need the further validation experiments.

从上面的工作可以知道，我们的系统已经基本分部分工作，并且目前的实验已经进入了整合 阶段，构建了包括。。。。。。。。。。一旦整合测试完成，我们 设想首先利用我们的系统进行单链抗体的定向进化。目前已经有较多的…………（引用，还没看）。另外我们也希望进行短肽（肽适体）的定向进化，……（引用）。 另外，做装置（真心不想写了，画图）

The Future System

Due to the lab conditions and time limits , at present our experimental design is not the best one. In current designs, one bacteria contains too many plasmids, which is a disadvantage for growth and protein expression of bacteria. We therefore consider whether we can split our system into two types of bacteria. So that the mutagenesis module can less effect to other part of the system.

In addition, because we couldn't find a suitable laboratory, we have to limit our ideas into prokaryotic organisms. In fact, the IgEM in prokaryotes has many big limitations. We know that many proteins come from eukaryotic cannot be folded correctly in prokaryotes. And also, prokaryotes lack the capacity of the post-translational modification of proteins, which is essential for protein function (such as antibodies). Therefore, in the future, we want to apply our IgEM in more organisms, such as yeast or mammalian cells. In this way, we can evolve more proteins, and can also solve the problems of protein post-translational modification and folding.